210 related articles for article (PubMed ID: 35008745)
1. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
[TBL] [Abstract][Full Text] [Related]
2. Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies.
Noborn F; Thomsen C; Vorontsov E; Bobbio E; Sihlbom C; Nilsson J; Polte CL; Bollano E; Vukusic K; Sandstedt J; Dellgren G; Karason K; Oldfors A; Larson G
Amyloid; 2023 Mar; 30(1):96-108. PubMed ID: 36209425
[TBL] [Abstract][Full Text] [Related]
3. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
Mollee P; Boros S; Loo D; Ruelcke JE; Lakis VA; Cao KL; Renaut P; Hill MM
Clin Proteomics; 2016; 13():30. PubMed ID: 27795698
[TBL] [Abstract][Full Text] [Related]
4. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
[TBL] [Abstract][Full Text] [Related]
5. [Proteomics, a new tool for an accurate typing of amyloidosis].
Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
[TBL] [Abstract][Full Text] [Related]
6. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.
Klein CJ; Vrana JA; Theis JD; Dyck PJ; Dyck PJ; Spinner RJ; Mauermann ML; Bergen HR; Zeldenrust SR; Dogan A
Arch Neurol; 2011 Feb; 68(2):195-9. PubMed ID: 20937937
[TBL] [Abstract][Full Text] [Related]
8. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
[TBL] [Abstract][Full Text] [Related]
9. Pathology and diagnosis of renal non-AL amyloidosis.
Sethi S; Theis JD
J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
[TBL] [Abstract][Full Text] [Related]
10. [New Insights into Diagnosis and Pathogenesis of Amyloidosis by Mass Spectrometric Analysis].
Tasaki M; Obayashi K; Ando Y
Rinsho Byori; 2016 Jun; 64(6):675-679. PubMed ID: 30695322
[TBL] [Abstract][Full Text] [Related]
11. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J
Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteome profiling provides evidence of an activation of the complement cascade in ATTR amyloidosis.
Treitz C; Gottwald J; Gericke E; Urban P; Meliß RR; Axmann HD; Siebert F; Becker K; Tholey A; Röcken C
Amyloid; 2022 Jun; 29(2):102-109. PubMed ID: 34913770
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of Mass Spectrometry-Based Targeted Analysis for Amyloid Proteins.
Park J; Lee GY; Choi JO; Jeon ES; Kim K; Kim JS; Lee SY
Proteomics Clin Appl; 2018 May; 12(3):e1700106. PubMed ID: 29266842
[TBL] [Abstract][Full Text] [Related]
14. Congophilic Fibrillary Glomerulonephritis: A Case Series.
Alexander MP; Dasari S; Vrana JA; Riopel J; Valeri AM; Markowitz GS; Hever A; Bijol V; Larsen CP; Cornell LD; Fidler ME; Said SM; Sethi S; Herrera Hernandez LP; Grande JP; Erickson SB; Fervenza FC; Leung N; Kurtin PJ; Nasr SH
Am J Kidney Dis; 2018 Sep; 72(3):325-336. PubMed ID: 29866458
[TBL] [Abstract][Full Text] [Related]
15. The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis.
Rezk T; Gilbertson JA; Mangione PP; Rowczenio D; Rendell NB; Canetti D; Lachmann HJ; Wechalekar AD; Bass P; Hawkins PN; Bellotti V; Taylor GW; Gillmore JD
J Pathol Clin Res; 2019 Jul; 5(3):145-153. PubMed ID: 30740936
[TBL] [Abstract][Full Text] [Related]
16. Immunoelectron microscopy and mass spectrometry for classification of amyloid deposits.
Abildgaard N; Rojek AM; Møller HE; Palstrøm NB; Nyvold CG; Rasmussen LM; Hansen CT; Beck HC; Marcussen N
Amyloid; 2020 Mar; 27(1):59-66. PubMed ID: 31752543
[TBL] [Abstract][Full Text] [Related]
17. Anakinra-Associated Systemic Amyloidosis.
Alehashemi S; Dasari S; Metpally A; Uss K; Castelo-Soccio LA; Heller T; Kellman P; Chen MY; Ahlman M; Kim J; Wargo S; Kuhns DB; Fink D; de Jesus A; Martin PS; Chang R; Bolanos J; Lee CR; Nasr SH; Goldbach-Mansky R; McPhail E
Arthritis Rheumatol; 2024 Jan; 76(1):100-106. PubMed ID: 37488949
[TBL] [Abstract][Full Text] [Related]
18. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.
Brambilla F; Lavatelli F; Di Silvestre D; Valentini V; Rossi R; Palladini G; Obici L; Verga L; Mauri P; Merlini G
Blood; 2012 Feb; 119(8):1844-7. PubMed ID: 21917755
[TBL] [Abstract][Full Text] [Related]
19. Confirming the Diagnosis of Amyloidosis.
Wisniowski B; Wechalekar A
Acta Haematol; 2020; 143(4):312-321. PubMed ID: 32544917
[TBL] [Abstract][Full Text] [Related]
20. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
Vrana JA; Theis JD; Dasari S; Mereuta OM; Dispenzieri A; Zeldenrust SR; Gertz MA; Kurtin PJ; Grogg KL; Dogan A
Haematologica; 2014 Jul; 99(7):1239-47. PubMed ID: 24747948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
